Status:
UNKNOWN
Respiferon Project
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Respiratory Viral Infection
Eligibility:
All Genders
Brief Summary
Respiratory viral infections (RVIs) represent a major public health problem and a great burden in terms of morbidity and mortality in children and adults worldwide. To ascertain the source of an infec...
Eligibility Criteria
Inclusion
- Positive nasopharyngeal samples for the detection of a virus, for which the replicative character has been established by the viral culture technique (500µL minimum required)
- Samples kept at the CRB since 2018
- Information to patients carried out and non-objection collected-
Exclusion
- N/A
Key Trial Info
Start Date :
November 11 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06017310
Start Date
November 11 2022
End Date
December 31 2024
Last Update
August 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Infective Agents Institute, Croix rousse Hospital
Lyon, Rhone, France, 69004